LifeMD, Inc.
For the period ended Sep 30, 2025. Filed Nov 17, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 17, 2025
LFMD$1.74-16.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Nine Months Ended September 30, | ||||
|---|---|---|---|---|
| 2025 · 2024 | ||||
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||
| Net loss | $(4,323,177) | $(16,233,314) | ||
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||||
| Amortization of debt discount | 234,369 | 301,331 | ||
| Amortization of capitalized software | 7,087,054 | 5,884,893 | ||
| Amortization of intangibles | 775,338 | 737,836 | ||
| Accretion of consideration payable | - | 13,644 | ||
| Loss on debt extinguishment | 1,155,851 | - | ||
| Depreciation of fixed assets | 609,569 | 321,698 | ||
| Noncash operating lease expense | 821,604 | 529,038 | ||
| Stock compensation expense | 7,841,178 | 9,129,841 | ||
| Changes in Assets and Liabilities | ||||
| Accounts receivable | 1,609,763 | (5,222,534) | ||
| Product deposit | (329,755) | 349,095 | ||
| Inventory | (635,024) | 114,489 | ||
| Other current assets | (580,382) | (2,303,495) | ||
| Operating lease liabilities | (248,574) | (446,682) | ||
| Deferred revenue | (5,270,408) | 10,874,430 | ||
| Accounts payable | 3,545,251 | 4,782,614 | ||
| Accrued expenses | (731,959) | 7,607,005 | ||
| Net cash provided by operating activities | 11,560,698 | 16,439,889 | ||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||
| Cash paid for capitalized software costs(a) | (8,446,187) | (7,546,346) | ||
| Purchase of equipment | (1,715,214) | (1,265,447) | ||
| Purchase of intangible assets | - | (3,798) | ||
| Net cash used in investing activities | (10,161,401) | (8,815,591) | ||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||
| Repayment of debt instruments | (18,719,721) | - | ||
| Sale of common stock under ATM, net | 8,721,717 | - | ||
| Preferred stock dividends | (2,329,688) | (2,329,688) | ||
| Repayment of notes payable, net of prepayment penalty | - | (327,597) | ||
| Cash proceeds from exercise of warrants | 464,950 | - | ||
| Cash proceeds from exercise of options | 5,950 | 107,813 | ||
| Contingent consideration payments for ResumeBuild acquisition | - | (31,250) | ||
| Distributions to non-controlling interest | (761,658) | (603,048) | ||
| Net cash used in financing activities | (12,618,450) | (3,183,770) | ||
| Net (decrease) increase in cash | (11,219,153) | 4,440,528 | ||
| Cash at beginning of period | 35,004,924 | 33,146,725 | ||
| Cash at end of period | $23,785,771 | $37,587,253 | ||
| Cash paid for interest and taxes | ||||
| Cash paid during the period for interest | $1,461,032 | $1,913,049 | ||
| Cash paid during the period for taxes | $482,471 | $198,176 | ||
| Non-cash investing and financing activities: | ||||
| Cashless exercise of options | $1,315 | $5,127 | ||
| Cashless exercise of warrants | $3,901 | $16,305 | ||
| Stock issued for debt conversion | $1,000,000 | $ | - | |
| Stock issued for asset acquisition | $303,000 | $ | - | |
| Stock issued for noncontingent consideration payment | $ | - | $642,000 | |
| Right of use assets | $ | - | $6,684,397 | |
| Operating lease liabilities | $ | - | $6,684,397 | |
| (a) | Approximately $2.9 million and $2.7 million was paid to a related party for capitalized software costs during the nine months ended September 30, 2025 and 2024, respectively. See Note 12—Related Party Transactions. |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.